Who owns Yarrow Bioscience, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of YARW from SEC Form 13F filings across 49 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 49 institutions disclosed 9.4M shares of Yarrow Bioscience, Inc. worth $212.2M — about 41.7% of shares outstanding; the largest disclosed holder is Logos Global Management LP. Source: SEC Form 13F filings, parsed by EvidInvest.
49
13F holders
$212.2M
value, 2026 filers
41.7%
of shares outstanding (9.4M sh)
49
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of YARW's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Logos Global Management LPNEW | 1.0M | $23.1M | 1.2% | 4.5% | new |
| 2 | Bellevue Group AGNEW | 1.0M | $22.5M | 0.5% | 4.4% | new |
| 3 | PERCEPTIVE ADVISORS LLCNEW | 813,098 | $18.3M | 0.3% | 3.6% | new |
| 4 | AMERIPRISE FINANCIAL INCNEW | 739,538 | $16.7M | 0.0% | 3.3% | new |
| 5 | Siren, L.L.C.NEW | 675,000 | $15.2M | 0.4% | 3% | new |
| 6 | Spruce Street Capital LPNEW | 607,382 | $13.7M | 2.2% | 2.7% | new |
| 7 | venBio Partners LLCNEW | 554,769 | $12.5M | 2.5% | 2.5% | new |
| 8 | Soleus Capital Management, L.P.NEW | 416,993 | $9.4M | 0.3% | 1.8% | new |
| 9 | VANGUARD CAPITAL MANAGEMENT LLCNEW | 368,034 | $8.3M | 0.0% | 1.6% | new |
| 10 | BRAIDWELL LPNEW | 331,400 | $7.5M | 0.3% | 1.5% | new |
| 11 | Driehaus Capital Management LLCNEW | 305,000 | $6.9M | 0.0% | 1.3% | new |
| 12 | SILVERARC CAPITAL MANAGEMENT, LLCNEW | 301,919 | $6.8M | 0.8% | 1.3% | new |
| 13 | CITADEL ADVISORS LLCNEW | 297,361 | $6.7M | 0.0% | 1.3% | new |
| 14 | Janus Henderson Group Ltd.NEW | 283,341 | $6.4M | 0.0% | 1.3% | new |
| 15 | ADAR1 Capital Management, LLCNEW | 282,996 | $6.4M | 0.3% | 1.3% | new |
| 16 | ORBIMED ADVISORS LLCNEW | 266,306 | $6.0M | 0.1% | 1.2% | new |
| 17 | MARSHALL WACE, LLPNEW | 237,183 | $5.3M | 0.0% | 1% | new |
| 18 | Squadron Capital Management LLCNEW | 225,000 | $5.1M | 1.3% | 1% | new |
| 19 | BlackRock, Inc.NEW | 89,892 | $2.0M | 0.0% | 0.4% | new |
| 20 | GEODE CAPITAL MANAGEMENT, LLCNEW | 84,720 | $1.9M | 0.0% | 0.4% | new |
| 21 | MORGAN STANLEYNEW | 68,094 | $1.5M | 0.0% | 0.3% | new |
| 22 | J. Goldman & Co LPNEW | 55,751 | $1.3M | 0.0% | 0.2% | new |
| 23 | VANGUARD FIDUCIARY TRUST CONEW | 50,629 | $1.1M | 0.0% | 0.2% | new |
| 24 | Seven Fleet Capital Management LPNEW | 40,000 | $900,800 | 0.2% | 0.2% | new |
| 25 | Monashee Investment Management LLCNEW | 40,000 | $900,800 | 2.7% | 0.2% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.